Reliability and Usability of Telemedicine evaluations for Facial Dystonia

Phase 4

• Conditions: facial dystonia Hemifacial spasm BlepharospasmTelemedicine; Facial dystonia; Blepharospasm; Hemifacial spasm; Botulinum toxin; Telemedicine; Reliability; Usability; Satisfaction

• Registration Number: TCTR20210508001
• Lead Sponsor: King Chulalongkorn Memorial Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-08
• Study Completion: 2022-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Age of at least 18 years old, 2. A diagnosis of facial dystonia including blepharospasm and hemifacial spasm, 3. Potential to communicate through Chulalongkorn hospital telemedicine application either by themselves or with helps from their caregivers

Exclusion Criteria

1. Neuromuscular diseases that could affect the results of the study including myasthenia gravis which produces clinical fluctuation related to time, 2. Inability to communicate through telemedicine such as severe dementia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Spasm severity and frequency of facial dystonia 6 months Jankovic Rating Scale

Secondary Outcome Measures

Name	Time	Method
Signs of complications after botulinum toxin injection 6 months present/absent,Symptoms of complications after botulinum toxin injection 6 months present/absent,Telemedicine usability 6 months Telehealth usability questionnaire ,Data on the decision for further botulinum toxin injection 3 months indicate/not indicate